Search

Your search keyword '"Scholl, Catharina"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Scholl, Catharina" Remove constraint Author: "Scholl, Catharina" Database Unpaywall Remove constraint Database: Unpaywall
42 results on '"Scholl, Catharina"'

Search Results

2. Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer’s disease mice

4. Whole genome transcriptome data from the WT cortex and hippocampus of female and male control and APP/PS1 Alzheimer's disease mice

6. List of Contributors

9. Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical Trial

11. Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

14. Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)–Never Change a Running System?

17. Association between miRNA signatures in serum samples from epidermal growth factor inhibitor treated patients and skin toxicity

18. CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System—Results From the ADRED Study

21. Impact of Zika Virus Infection on Human Neural Stem Cell MicroRNA Signatures

23. Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients

24. Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study

25. Green tea extract to prevent colorectal adenomas in men and women: Results of the MIRACLE trial.

27. Adverse Drug Reactions (ADR) and Emergencies

28. Population nutrikinetics of green tea extract

29. Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash

30. Dosing to rash? – The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash

32. High-throughput screening identified inherited genetic variations in the EGFR pathway contributing to skin toxicity of EGFR inhibitors

33. CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study

34. Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients

36. Proliferation and cilia dynamics in neural stem cells prospectively isolated from the SEZ

Catalog

Books, media, physical & digital resources